Cytokinetics (CYTK) EPS (Basic) (2010 - 2026)

Cytokinetics (CYTK) posted quarterly EPS (Basic) of -$1502.4 for Q1 2026, down 7.71% year-over-year from -$1627.9 in Q1 2025, and down 2.55% quarter-over-quarter from -$1465.1 in Q4 2025.

Cytokinetics (CYTK) EPS (Basic) (2010 - 2026) Analysis & Trends

Cytokinetics (CYTK) has reported EPS (Basic) for 17 consecutive years, with -$1502.4 the latest figure, recorded in Q1 2026.

  • In Q1 2026, EPS (Basic) fell 7.71% year-over-year to -$1502.4; the TTM figure through Mar 2026 stood at -$5456.6 (down 6.61% YoY), while the FY2025 annual figure was -$7640.6, up 31.51% from the prior year.
  • EPS (Basic) slipped to -$1502.4 in Q1 2026 per CYTK's latest filing, from -$1465.1 in the prior quarter.
  • Across five years, EPS (Basic) topped out at -$159.58 in Q2 2022 and bottomed at -$1574.3 in Q3 2025.
  • Historically, EPS (Basic) has averaged -$1261.4 across 5 years, with a median of -$1338.7 in 2024.
  • Annual changes were most pronounced in 2022 — EPS (Basic) jumped 88.6% — and 2023, when it slumped 744.82%.
  • Cytokinetics' EPS (Basic) stood at -$1568.5 in 2022, then rose by 23.0% to -$1207.7 in 2023, then dropped by 9.85% to -$1326.7 in 2024, then slipped by 10.43% to -$1465.1 in 2025, then declined by 2.55% to -$1502.4 in 2026.
  • Business Quant data shows CYTK's EPS (Basic) at -$1502.4 in Q1 2026, -$1465.1 in Q4 2025, and -$1574.3 in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EPS (Basic) (Qtr)
1 Vertex Pharmaceuticals 128.13 Bn 120.28 Bn 2.84 Bn 4.34
2 Regeneron Pharmaceuticals 112.33 Bn 104.33 Bn 3.93 Bn 12.62
3 Argenx Se 53.24 Bn 48.05 Bn 1.41 Bn 7.59
4 Revolution Medicines 43.64 Bn 43.64 Bn - -3.06
5 BeOne Medicines 39.27 Bn 34.17 Bn 1.53 Bn 0.16
6 MindWalk Holdings 35.32 Bn 35.31 Bn 1.82 Bn 0.00
7 Royalty Pharma 33.72 Bn 35.84 Bn - 0.18
8 Alnylam Pharmaceuticals 30.58 Bn 27.27 Bn 992.69 Mn 1.23
9 Insmed 27.01 Bn 25.85 Bn 358.27 Mn -0.06
10 Cytokinetics 10.31 Bn 9.14 Bn 25.89 Mn -1.39

Historic Data

Download Data
DateValue
Jun 30, 2026 -1,387.33
Mar 31, 2026 -1,502.38
Dec 31, 2025 -1,465.08
Sep 30, 2025 -1,574.34
Jun 30, 2025 -1,026.23
Mar 31, 2025 -1,394.80
Dec 31, 2024 -1,326.67
Sep 30, 2024 -1,272.29
Jun 30, 2024 -1,308.17
Mar 31, 2024 -1,338.65
Dec 31, 2023 -1,207.69
Sep 30, 2023 -1,346.93
Jun 30, 2023 -1,348.17
Mar 31, 2023 -1,381.13
Dec 31, 2022 -1,568.48
Sep 30, 2022 -1,229.18
Jun 30, 2022 -159.58
Mar 31, 2022 -993.23
Dec 31, 2021 -344.39
Sep 30, 2021 -1,410.65